vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and SHORE BANCSHARES INC (SHBI). Click either name above to swap in a different company.
SHORE BANCSHARES INC is the larger business by last-quarter revenue ($59.1M vs $44.9M, roughly 1.3× AbCellera Biologics Inc.). On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 11.8%). SHORE BANCSHARES INC produced more free cash flow last quarter ($59.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 11.3%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Shore Bancshares Inc. is a U.S. regional bank holding company headquartered in Maryland. It offers a full range of retail and commercial banking services, including deposit products, personal and commercial loans, and wealth management solutions, primarily serving local individual customers, small businesses and mid-sized enterprises in its operating regions.
ABCL vs SHBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $59.1M |
| Net Profit | $-8.9M | — |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 35.2% |
| Net Margin | -19.9% | — |
| Revenue YoY | 788.4% | 11.8% |
| Net Profit YoY | 73.9% | — |
| EPS (diluted) | $-0.03 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $59.1M | ||
| Q3 25 | $9.0M | $56.4M | ||
| Q2 25 | $17.1M | $56.6M | ||
| Q1 25 | $4.2M | $53.0M | ||
| Q4 24 | $5.0M | $52.9M | ||
| Q3 24 | $6.5M | $50.5M | ||
| Q2 24 | $7.3M | $50.6M | ||
| Q1 24 | $10.0M | $47.7M |
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $14.3M | ||
| Q2 25 | $-34.7M | $15.5M | ||
| Q1 25 | $-45.6M | $13.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-51.1M | $11.2M | ||
| Q2 24 | $-36.9M | $11.2M | ||
| Q1 24 | $-40.6M | $8.2M |
| Q4 25 | -63.7% | 35.2% | ||
| Q3 25 | -851.8% | 33.7% | ||
| Q2 25 | -290.2% | 36.5% | ||
| Q1 25 | -1479.6% | 34.4% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | -1439.4% | 29.6% | ||
| Q2 24 | -1276.2% | 29.7% | ||
| Q1 24 | -551.5% | 22.2% |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | 25.5% | ||
| Q2 25 | -203.3% | 27.4% | ||
| Q1 25 | -1077.2% | 26.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -785.4% | 22.1% | ||
| Q2 24 | -504.3% | 22.2% | ||
| Q1 24 | -408.0% | 17.2% |
| Q4 25 | $-0.03 | $0.48 | ||
| Q3 25 | $-0.19 | $0.43 | ||
| Q2 25 | $-0.12 | $0.46 | ||
| Q1 25 | $-0.15 | $0.41 | ||
| Q4 24 | — | $0.39 | ||
| Q3 24 | $-0.17 | $0.34 | ||
| Q2 24 | $-0.13 | $0.34 | ||
| Q1 24 | $-0.14 | $0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $355.6M |
| Total DebtLower is stronger | — | $89.1M |
| Stockholders' EquityBook value | $966.9M | $589.9M |
| Total Assets | $1.4B | $6.3B |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $355.6M | ||
| Q3 25 | $83.2M | $416.5M | ||
| Q2 25 | $92.4M | $185.0M | ||
| Q1 25 | $159.3M | $389.0M | ||
| Q4 24 | $156.3M | $459.9M | ||
| Q3 24 | $126.6M | $183.6M | ||
| Q2 24 | $148.3M | $138.9M | ||
| Q1 24 | $123.6M | $114.6M |
| Q4 25 | — | $89.1M | ||
| Q3 25 | — | $74.5M | ||
| Q2 25 | — | $74.2M | ||
| Q1 25 | — | $74.0M | ||
| Q4 24 | — | $73.7M | ||
| Q3 24 | — | $123.5M | ||
| Q2 24 | — | $122.8M | ||
| Q1 24 | — | $72.6M |
| Q4 25 | $966.9M | $589.9M | ||
| Q3 25 | $964.0M | $577.2M | ||
| Q2 25 | $1.0B | $565.2M | ||
| Q1 25 | $1.0B | $552.5M | ||
| Q4 24 | $1.1B | $541.1M | ||
| Q3 24 | $1.1B | $533.3M | ||
| Q2 24 | $1.1B | $522.8M | ||
| Q1 24 | $1.1B | $515.2M |
| Q4 25 | $1.4B | $6.3B | ||
| Q3 25 | $1.4B | $6.3B | ||
| Q2 25 | $1.4B | $6.0B | ||
| Q1 25 | $1.3B | $6.2B | ||
| Q4 24 | $1.4B | $6.2B | ||
| Q3 24 | $1.4B | $5.9B | ||
| Q2 24 | $1.4B | $5.9B | ||
| Q1 24 | $1.5B | $5.8B |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $62.4M |
| Free Cash FlowOCF − Capex | $-44.6M | $59.2M |
| FCF MarginFCF / Revenue | -99.4% | 100.2% |
| Capex IntensityCapex / Revenue | 21.9% | 5.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $110.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $62.4M | ||
| Q3 25 | $-52.6M | $42.5M | ||
| Q2 25 | $-32.4M | $-8.3M | ||
| Q1 25 | $-11.6M | $19.8M | ||
| Q4 24 | $-108.6M | $46.9M | ||
| Q3 24 | $-28.9M | $9.1M | ||
| Q2 24 | $-30.0M | $3.0M | ||
| Q1 24 | $-41.7M | $2.4M |
| Q4 25 | $-44.6M | $59.2M | ||
| Q3 25 | $-61.5M | $41.9M | ||
| Q2 25 | $-45.8M | $-9.2M | ||
| Q1 25 | $-22.2M | $18.8M | ||
| Q4 24 | $-187.0M | $41.7M | ||
| Q3 24 | $-47.4M | $8.4M | ||
| Q2 24 | $-50.1M | $1.4M | ||
| Q1 24 | $-65.8M | $614.0K |
| Q4 25 | -99.4% | 100.2% | ||
| Q3 25 | -687.0% | 74.3% | ||
| Q2 25 | -267.9% | -16.3% | ||
| Q1 25 | -524.0% | 35.4% | ||
| Q4 24 | -3702.8% | 78.8% | ||
| Q3 24 | -728.4% | 16.7% | ||
| Q2 24 | -683.8% | 2.9% | ||
| Q1 24 | -661.5% | 1.3% |
| Q4 25 | 21.9% | 5.4% | ||
| Q3 25 | 99.7% | 1.0% | ||
| Q2 25 | 78.2% | 1.6% | ||
| Q1 25 | 251.1% | 1.9% | ||
| Q4 24 | 1552.7% | 9.9% | ||
| Q3 24 | 284.6% | 1.2% | ||
| Q2 24 | 274.6% | 3.1% | ||
| Q1 24 | 242.5% | 3.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | -0.54× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.81× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
